# Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria

> **NCT00004397** · PHASE1 · COMPLETED · sponsor: **National Center for Research Resources (NCRR)** · enrollment: 20 (—)

## Conditions studied

- Porphyria

## Interventions

- **DRUG:** heme arginate
- **DRUG:** tin mesoporphyrin

## Key facts

- **NCT ID:** NCT00004397
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** —
- **Final completion:** 2000-05
- **Target enrollment:** 20 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004397, "Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00004397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*